Abstract
Surgical treatment of adenocarcinoma of the esophagus and gastroesophageal junction is complex and challenging. Huge variation exist in the immediate and long term outcomes of such interventions and it is generally accepted that this is a direct consequence of the experience of the surgical team. However beside surgical quality many other indicators of quality management may influence outcome. Definition of the gastroesophageal junction remains controversial and the performance of staging procedures i.e. CT scan, endoscopy and fine needle aspiration, PET scan still suboptimal. As a result there is disagreement on the selection of patients for surgery, type of surgical approach in particular in relation to the extent of lymph node dissection as well as the extent of esophageal and/or gastric resection. In the design of randomized controlled trials comparing primary surgery versus multimodality treatment surgical quality criteria are notoriously lacking. It therefore remains a matter of debate which patients eventually will benefit from primary surgery versus those who will benefit from induction therapy. A lack of surgical quality indicators is also very prominent when assessing the value of new surgical technologies such as minimally invasive surgery or robotic surgery. Improvements in this wide spectrum of aspects is mandatory and will certainly be of great value to further improve both short and long term outcome after surgery for these complex cancers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Altorki N (2005) En-bloc esophagectomy. The three-field dissection. Surg Clin N Am 85:611–619
Ancona E, Ruol A, Santi S et al (2001) Only pathologic complete response to neoadjuvant chemo-therapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma. Cancer 91:2165–2174
Bandstrup B (2006) Fluid therapy for the surgical patient. Best Pract Res Clin Anesthesiol 20:265–283
Bedenne L, Michel P, Bouché O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz J, Herr J, Paillot B, Arveux P, Bonnetain F, Binquet C (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–1168
Birkmeyer JD, Siewers AE, Finlayson EVA, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137
Birkmeyer JD, Sun Y, Wong SL, Stukel TA (2007) Hospital volume and late survival after cancer surgery. Ann Surg 245:777–783
Blumenthal D (1996) Measuring quality of care. New Engl J Med 335:966–970
Bandstrup B, Tonnesen H, Beier-Holgersen R, Hjortso E, Ording H, Lindorff-Larsen K et al (2003) Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 238:641–648
Cerfolio RJ, Bryant AS, Bass CS, Alexander JR, Bartolucci AA (2004) Fast tracking after Ivor Lewis esophagogastrectomy. Chest 126:1187–1194
Chang AC, Ji H, Birkmeyer NJ, Orringer MB, Birkmeyer JD (2008) Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 85:424–429
Chemaly M, Scalone O, Durivage G, Napoleon B, Pujol B, Lefort C, Hervieux V, Scoazec JY, Souquet JC, Ponchon T (2008) Miniprobe EUS in the pretherapeutic assessment of early esophageal neoplasia. Endoscopy 40:2–6
Cushieri A, Shimi S, Banting S (1992) Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 37:7–11
De Manzoni G, Pedrazzani C, di Leo A et al (1999) Experience of endoscopic ultrasound with a 20-Mhz ultrasound thin probe. Eur J Surg Oncol 25:595–598
Decker G, Coosemans W, De Leyn P, Decaluwé H, Nafteux P, Van Raemdonck D, Lerut T (2009) Minimally invasive esophagectomy for cancer. Eur J Cardiothorac Surg 35:13–21
Driessen A, Van Raemdonck D, De Leyn P et al (2003) Are carcinomas of the cardia oesophageal or gastric adenocarcinomas? Eur J Cancer 39:2487–2494
Driessen A, Nafteux P, Lerut T et al (2004) Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications. Mod Pathol 17:49–55
Edge S.B, Byrd D.R., Compton C, Fritz A.G., Greene F.L., Trotti A (2009) AJCC Cancer Staging Manual 7th Edition, Springer, New York
Egger M, Ebrahim S, Smith GD (2002) Where now for meta-analysis? Int J Epidemiol 31:1–5
Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349:2241–2252
Fiorica F, Di Bona D, Schepsis F et al (2004) Preoperative chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis. Gut 53:925–930
Fumagalli U (1996) Resective surgery for cancer of thoracic esophagus. Results of a consensus conference of the International Society for Diseases of the Esophagus. Dis Esophagus 9:30–38
Gebski V, Burmeister B, Smithers B, Foo K, Zalcberg J, Simes J, Australasian Gastro-Intestinal Trials Group (2007) Survival benefits for neo-adjuvant chemoradiotherapy or chemo-therapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234
Geh JI, Bond SJ, Bentzen SM et al (2006) Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 78:236–244
Greene FL, Page DL, Fleming ID, Fritz AG, Balck CM, Haller DG, Morrow M (2002) AJCC cancer staging handbook. TNM classification of malignant tumors, 6th edn. Springer, New York
Greer S, Goodney P, Sutton J, Birkmeyer J (2005) Neo-adjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 137: 172–177
Guideline for the esophageal and gastric cancer: scientific support of the college of Oncology. www.kce.fgov.be. 21 Mar 2008
Holte K, Kehlet H (2006) Fluid therapy and surgical outcomes in elective surgery: a need for reassessment in fast-track surgery. J Am Coll Surg 202:971–989
Hulscher JBF, Tijssen JGP, Obertop H, van Lanschot JJB (2001) Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thor Surg 72:306–313
Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12
Joshi GP (2005) Intraoperative fluid restriction improves outcome after major elective gastrointestinal surgery. Anesth Analg 101:601–605
Kelly S, Harris KM, Berry E et al (2001) A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 49:534–539
Kelsen D, Ginsberg R, Pajak T, Sheahan D, Gunderson L, Mortimer J, Estes N, Haller D, Ajani J, Kocha W, Minsky B, Roth J (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979–1984
Kutup A, Link BC, Schurr PG, Strate T, Kaifi JT, Bubenheim M, Seewald S, Yekebas EF, Soehendra N, Izbicki JR (2007) Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer. Endoscopy 39:715–719
Lagarde SM, ten Kate FJ et al (2006) Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 24:4347–4355
Law S (2006) Minimally invasive techniques for oesophageal cancer surgery. Best Pract Res Clin Gastroent 20:925–940
Lerut T, Coosemans W, De Leyn P, Van Raemdonck D, Nafteux P, Moons J (2001) Optimizing treatment of carcinoma of the esophagus and gastroesophageal junction. Surg Clin North Am 10:863–884
Lerut T, Coosemans W, Decker G, De Leyn P, Ectors N, Fieuws S, Moons J, Nafteux P, Van Raemdonck D; for the Leuven Collaborative Workgroup for Esophageal Carcinoma (2003) Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction. J Thor Cardiovasc Surg 126:1121–1128
Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Ectors N (2004) Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240:962–974
Lerut T, Moons J, Coosemans W, Decaluwé H, Decker G, De Leyn P, Nafteux P, VanRaemdonck D (2008) Multidisciplinary treatment of advanced cancer of the esophagus and gastroesophageal junction: a European center’s approach. Surg Oncol Clin N Am 17:485–502
Lightdale CJ, Kulkarni KG (2005) Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol 23:4483–4489
Low DE (2007) Evolution in perioperative management of patients undergoing oesophagectomy. Br J of Surg 94:655–656
Luketich JD, Alvelo-Rivera M, Buenaventura PO, Christie NA, McCaughan JS, Litle VR, Schauer PR, Close JM, Fernando HC (2003) Minimally invasive esophagectomy. Outcomes in 222 patients. Ann Surg 238:486–495
Malthaner R, Fenlon D (2003) Preoperative chemotherapy for resectable esophageal cancer. Cochrane Database Syst Rev (4):CD001556
Malthaner R, Wong R, Rumble R, Zuraw L (2004) Gastrointestinal Disease Group of Cancer Care Ontario’s Program in evidence-based care. Neo-adjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline. BMC Cancer 4:67
May A, Günter E, Roth F, Gossner L, Stolte M, Vieth M, Ell C (2004) Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective and blinded trial. Gut 53:634–640
Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359:1727–1734
Meyers BF, Downey RJ, Decker PA, Keenan RJ, Siegel BA, Cerfolio RJ, Landreneau RJ, Reed CE, Balfe DM, Dehdashti F, Ballman KV, Rusch VW, Putnam JB (2007) The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg 133:738–745
NCCN. NCCN (2002) clinical practice guidelines in oncology: esophageal cancer. Version 2009. www.nccn.org
Nishimaki T (2006) An appropriate esophagectomy for esophageal cancer: a lack of evidence and a growing disparity between Western and Eastern standards. Ann Thorac Cardiovasc Surg 12:231–233
Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, Ten Kate FJ, Obertop H, Tilanus HW, van Lanschot JJ (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246:992–1000
Pera M, Manterola C et al (2005) Epidemiology of esophageal adenocarcinoma. J Surg Oncol 92: 151–9
Peters FP, Brakenhoff KPM, Curvers WL, Rosmolen WD, Fockens P, ten Kate FJW, Krishnadath KK, Bergman JJ (2008) Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett’s esophagus. Gastroint Endosc 67:604–609
Peyre C, Hagen J, DeMeester SR, Altorki NK, Ancona E, Griffin SM, Hölscher A, Lerut T, Law S, Rice T, Ruol A, van Lanschot JJB, Wong J, De Meester TR (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248:549–555
Rindani R, Martin CJ, Cox MR (1999) Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference? Aust NZ J Surg 69:187–194
Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459
Smithers BM, Gotley DC, Martin I, Thomas JM (2007) Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg 245:232–240
Sobin LH, Wittekind C (eds) (2002) International Union against cancer (IUICC) TNM classification of malignant tumours, 6th edn. Wiley-Liss, New-York
Spechler SJ, Dixon MF, Genta R, Hainaut P, Lambert R, Siewert R (2000) Adenocarcinoma of the esophago-gastric junction. In: Hamilton SR, Aaltonen LA (eds) World Health Organization classification of tumours, vol 2. Pathology and genetics of tumours of the digestive system. IARC, Lyon, France, pp 31–36
Stahl M, Stuschke M, Lehmann N, Meyer H, Walz M, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. JCO 23:2310
Urschel J, Vasan H (2003) A meta-analysis of randomized controlled trials that compared neo-adjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538–543
van Lanschot JJ, Hulscher JB, Buskens CJ, Tilanus HW, ten Kate FJ, Obertop H (2001) Hospital volume and hospital mortality for esophagectomy. Cancer 91:1574–1578
Van Raemdonck D, Van Cutsem E, Menten J, Ectors N, Coosemans W, De Leyn P, Lerut T (1997) Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration. Eur J Cardiothorac Surg 11:828–837
Van Vliet EP, Eijkemans MJ et al (2006) Staging of esophageal carcinoma in a low-volume EUS center compared with results from high-volume centers. Gastrointest Endosc 63:938–947
Van Vliet EP, Hermans JJ, De Wever W, Eijkemans MJ, Steyerberg EW, Faasse C, van Helmond EP, de Leeuw AM, Sikkenk AC, de Vries AR, de Vries EH, Kuipers EJ, Siersema PD (2008) Radiologist experience and CT examination quality determine metastasis detection in patients with esophageal or gastric cardia cancer. Eur Radiol 18:2475–2484
Vrouenraets BC, van Lanschot JJB (2006) Extent of surgical resection for esophageal and gastroesophageal junction adenocarcinomas. Surg Oncol Clin N Am 15:781–791
Walsh T, Noonan N, Hollywood D et al (1996) Comparison of multimodal therapy and surgery for oesophageal adenocarcinoma. N Engl J Med 335:462–467
Wittekind C, Green FL, Henson DE, Hutter RVP, Sobin LH (2003) TNM supplement: a commentary on uniform use, 3rd edn. Wiley-Liss, New-York
Yamamoto S, Kawahara K, Maekawa T, Shiraishi T, Shirakusa T (2005) Minimally invasive esophagectomy for stage I and II esopageal cancer. Ann Thor Surg 80:2070–2075
Zher KJ, Dawson PB, Yang SC, Heitmiller RF (1998) Standardized clinical care pathways for major thoracic cases reduces hospital costs. Ann Thorac Surg 66:914–919
Zuccaro G, Rice TW, Vargo JJ et al (2005) Endoscopic ultrasound errors in esophageal cancer. Am J Gastroenterol 100:1216 (The authors describe the difficulties in discriminating between pT1b-T2 and pT3-T4 withpT3-T4 with misclassification by EUS of disease extent in 15%)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lerut, T. et al. (2009). Quality Indicators of Surgery for Adenocarcinoma of the Esophagus and Gastroesophageal Junction. In: Schneider, P. (eds) Adenocarcinoma of the Esophagogastric Junction. Recent Results in Cancer Research, vol 182. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-70579-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-540-70579-6_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-70578-9
Online ISBN: 978-3-540-70579-6
eBook Packages: MedicineMedicine (R0)